Cite Filings / VNDA / 0001628280-22-003629

Feed Companies Filings Check

Sign in

10-K

Annual Report

Vanda Pharmaceuticals Inc. Filed 2022-02-24 Acc 0001628280-22-003629

Documents 1

10-K Annual Report , vnda-20211231.htm

Around this filing

2023-02-09 10-K Annual Report
2022-03-02 4 SVP & General Counsel sold 12,060 shares at $11.09 ($133,779)
2022-03-02 4 Changes in Ownership
2022-03-01 8-K Executive or director change
2022-02-24 10-K Annual Report
2022-02-23 8-K Results of operations
2021-02-11 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading vnda-20211231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…